Thursday, June 14, 2018 1:46:05 PM
Am I willing to let money sit for that long? Probably not, but I'll watch and swing trade it.
Is CS CBD better than Hemp CBD, probably, but that doesn't mean there's no business or profits here. Maybe it's used as an additive or dilution/filler for better stock. Maybe they figure our how to mix a little something with it to kick up the entourage effect a little.
If nothing else, I see a small spec play here, but there's some real potential... things could either bleed sideways with pops on the unwinding of conversion shares. OR it could blossom into a really nice play should things "get serious" (i.e uplisting fed regs change etc...)
The risks I see are no more than most- the pro's I see are that they have solid established rev streams that are increasing. The regulation issue alone has great pop potential. It's got steady volume, not huge, but steady, which means it will see "good volume" should solid news occur.
That's my take.
Nothing I say, post, or do should ever be considered financial
advice. I may be holding a long, short or no position. Anything I
write may be truth or fiction and should not be considered facts. I
am NOT and NEVER have been compensated to post on here.
FEATURED Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • May 16, 2024 8:13 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM
Integrated Ventures Files Q3/2024 With Mining Revenues Of $1,983,250 And Positive Earnings Of $0.05 Cents Per Share • INTV • May 15, 2024 10:30 AM
Swifty Global Announces Impressive Financial Results for Q1 2024 • DRCR • May 15, 2024 10:25 AM